Clinical trial
INfections in Patients Treated With CAR-T: Analysis of Incidence, Risk Factors, and Management Strategies
NCT07713511 is registered in ClinicalTrials.gov with IRCCS Azienda Ospedaliero-Universitaria di Bologna as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- INfections in Patients Treated With CAR-T: Analysis of Incidence, Risk Factors, and Management Strategies
- Lead sponsor
- IRCCS Azienda Ospedaliero-Universitaria di Bologna
- Phase
- Observational
- Overall status
- Not yet recruiting
- Start date
- November 1, 2026
- Completion date
- April 30, 2029
- Enrollment
- 290 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
b-cell non-hodgkin lymphoma, bloodstream infections, car-t cell therapy, refractory multiple myeloma, relapsed multiple myeloma